| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 2.56e-05 | 20 | 58 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.55e-04 | 36 | 58 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 4.39e-04 | 51 | 58 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA editing activity | 7.38e-04 | 14 | 58 | 2 | GO:0002161 | |
| GeneOntologyMolecularFunction | sodium ion binding | 7.38e-04 | 14 | 58 | 2 | GO:0031402 | |
| GeneOntologyCellularComponent | extracellular matrix | 8.64e-05 | 656 | 59 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 8.84e-05 | 658 | 59 | 9 | GO:0030312 | |
| MousePheno | abnormal head movements | 3.21e-05 | 103 | 50 | 5 | MP:0000436 | |
| Domain | PINIT | 1.13e-07 | 4 | 58 | 3 | IPR023321 | |
| Domain | PINIT | 1.13e-07 | 4 | 58 | 3 | PS51466 | |
| Domain | PINIT | 1.13e-07 | 4 | 58 | 3 | PF14324 | |
| Domain | zf-MIZ | 9.86e-07 | 7 | 58 | 3 | PF02891 | |
| Domain | ZF_SP_RING | 9.86e-07 | 7 | 58 | 3 | PS51044 | |
| Domain | Znf_MIZ | 1.57e-06 | 8 | 58 | 3 | IPR004181 | |
| Domain | USP_C | 2.84e-05 | 3 | 58 | 2 | IPR029346 | |
| Domain | USP7_C2 | 2.84e-05 | 3 | 58 | 2 | PF14533 | |
| Domain | - | 3.63e-05 | 21 | 58 | 3 | 1.10.720.30 | |
| Domain | SAP | 4.20e-05 | 22 | 58 | 3 | PF02037 | |
| Domain | SAP | 4.82e-05 | 23 | 58 | 3 | SM00513 | |
| Domain | Ubiquitin_3 | 5.66e-05 | 4 | 58 | 2 | PF14836 | |
| Domain | Ub_USP-typ | 5.66e-05 | 4 | 58 | 2 | IPR028135 | |
| Domain | SAP | 6.23e-05 | 25 | 58 | 3 | PS50800 | |
| Domain | SAP_dom | 6.23e-05 | 25 | 58 | 3 | IPR003034 | |
| Domain | DUSP | 1.41e-04 | 6 | 58 | 2 | SM00695 | |
| Domain | Na_trans_cytopl | 1.41e-04 | 6 | 58 | 2 | PF11933 | |
| Domain | Val/Leu/Ile-tRNA-synth_edit | 1.41e-04 | 6 | 58 | 2 | IPR009008 | |
| Domain | Anticodon_1 | 1.41e-04 | 6 | 58 | 2 | PF08264 | |
| Domain | M/V/L/I-tRNA-synth_anticd-bd | 1.41e-04 | 6 | 58 | 2 | IPR013155 | |
| Domain | DUSP | 1.41e-04 | 6 | 58 | 2 | PF06337 | |
| Domain | - | 1.41e-04 | 6 | 58 | 2 | 3.90.740.10 | |
| Domain | Na_trans_cytopl | 1.41e-04 | 6 | 58 | 2 | IPR024583 | |
| Domain | aa-tRNA-synth_Ia | 1.97e-04 | 7 | 58 | 2 | IPR002300 | |
| Domain | - | 1.97e-04 | 7 | 58 | 2 | 3.30.2230.10 | |
| Domain | DUSP | 1.97e-04 | 7 | 58 | 2 | PS51283 | |
| Domain | tRNA-synt_1 | 1.97e-04 | 7 | 58 | 2 | PF00133 | |
| Domain | Pept_C19_DUSP | 1.97e-04 | 7 | 58 | 2 | IPR006615 | |
| Domain | VWF_dom | 2.99e-04 | 42 | 58 | 3 | IPR001007 | |
| Domain | Na_channel_asu | 4.20e-04 | 10 | 58 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 4.20e-04 | 10 | 58 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 4.20e-04 | 10 | 58 | 2 | PF06512 | |
| Domain | Ion_trans_dom | 4.33e-04 | 114 | 58 | 4 | IPR005821 | |
| Domain | Ion_trans | 4.33e-04 | 114 | 58 | 4 | PF00520 | |
| Domain | - | 5.12e-04 | 11 | 58 | 2 | 1.10.730.10 | |
| Domain | Sushi | 5.64e-04 | 52 | 58 | 3 | PF00084 | |
| Domain | CCP | 6.30e-04 | 54 | 58 | 3 | SM00032 | |
| Domain | SUSHI | 7.01e-04 | 56 | 58 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 7.38e-04 | 57 | 58 | 3 | IPR000436 | |
| Domain | Channel_four-helix_dom | 7.38e-04 | 57 | 58 | 3 | IPR027359 | |
| Domain | - | 7.38e-04 | 57 | 58 | 3 | 1.20.120.350 | |
| Domain | tRNAsynth_Ia_anticodon-bd | 9.70e-04 | 15 | 58 | 2 | IPR009080 | |
| Domain | USP_CS | 1.13e-03 | 66 | 58 | 3 | IPR018200 | |
| Domain | USP_1 | 1.34e-03 | 70 | 58 | 3 | PS00972 | |
| Domain | UCH | 1.40e-03 | 71 | 58 | 3 | PF00443 | |
| Domain | USP_2 | 1.40e-03 | 71 | 58 | 3 | PS00973 | |
| Domain | aa-tRNA-synth_I_CS | 1.40e-03 | 18 | 58 | 2 | IPR001412 | |
| Domain | USP_3 | 1.46e-03 | 72 | 58 | 3 | PS50235 | |
| Domain | USP_dom | 1.46e-03 | 72 | 58 | 3 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.46e-03 | 72 | 58 | 3 | IPR001394 | |
| Domain | PRAME_family | 1.57e-03 | 19 | 58 | 2 | IPR026271 | |
| Domain | AA_TRNA_LIGASE_I | 1.57e-03 | 19 | 58 | 2 | PS00178 | |
| Domain | Bromodomain_CS | 2.94e-03 | 26 | 58 | 2 | IPR018359 | |
| Domain | VWC | 3.40e-03 | 28 | 58 | 2 | PF00093 | |
| Domain | VWFC_1 | 5.58e-03 | 36 | 58 | 2 | PS01208 | |
| Domain | BROMODOMAIN_1 | 5.89e-03 | 37 | 58 | 2 | PS00633 | |
| Domain | EGF_3 | 6.09e-03 | 235 | 58 | 4 | PS50026 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS | 2.14e-05 | 16 | 49 | 3 | MM14938 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS | 4.32e-05 | 20 | 49 | 3 | M27237 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.81e-05 | 61 | 49 | 4 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 8.41e-05 | 67 | 49 | 4 | M26999 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 1.22e-04 | 28 | 49 | 3 | MM15042 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.38e-04 | 76 | 49 | 4 | MM14573 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 1.50e-04 | 30 | 49 | 3 | M27323 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.64e-04 | 90 | 49 | 4 | M631 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.56e-04 | 40 | 49 | 3 | MM15000 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 4.73e-04 | 44 | 49 | 3 | M27295 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M22027 | |
| Pathway | KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS | 6.38e-04 | 11 | 49 | 2 | M17946 | |
| Pathway | PID_RANBP2_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M140 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.90e-04 | 50 | 49 | 3 | MM14796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.23e-03 | 61 | 49 | 3 | M27103 | |
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 30861611 | ||
| Pubmed | PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. | 4.64e-09 | 3 | 59 | 3 | 12077349 | |
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 15907835 | ||
| Pubmed | SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death. | 4.63e-08 | 5 | 59 | 3 | 28622293 | |
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 27703003 | ||
| Pubmed | Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. | 9.24e-08 | 6 | 59 | 3 | 16029420 | |
| Pubmed | 1.62e-07 | 7 | 59 | 3 | 9724754 | ||
| Pubmed | Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling. | 1.62e-07 | 7 | 59 | 3 | 19217413 | |
| Pubmed | USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. | 2.58e-07 | 8 | 59 | 3 | 22706160 | |
| Pubmed | 2.58e-07 | 8 | 59 | 3 | 11117529 | ||
| Pubmed | 2.58e-07 | 8 | 59 | 3 | 16522640 | ||
| Pubmed | A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation. | 3.87e-07 | 9 | 59 | 3 | 17533377 | |
| Pubmed | 7.58e-07 | 11 | 59 | 3 | 27009683 | ||
| Pubmed | 7.58e-07 | 11 | 59 | 3 | 28842558 | ||
| Pubmed | Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis. | 1.01e-06 | 12 | 59 | 3 | 30612578 | |
| Pubmed | Foxp1 regulation of neonatal vocalizations via cortical development. | 1.31e-06 | 13 | 59 | 3 | 29138280 | |
| Pubmed | CFH PIAS3 SACS KLHL7 USP11 TFIP11 SORBS1 PIAS2 LRP1B PIAS1 TF VARS1 | 1.38e-06 | 1285 | 59 | 12 | 35914814 | |
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 2.83e-06 | 2 | 59 | 2 | 37901435 | |
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 2.83e-06 | 2 | 59 | 2 | 26410685 | |
| Pubmed | Isolation and characterization of the mouse ubiquitin-specific protease Usp15. | 2.83e-06 | 2 | 59 | 2 | 12532266 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 33411788 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 31084243 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 31943325 | ||
| Pubmed | Super-resolution study of PIAS SUMO E3-ligases in hippocampal and cortical neurons. | 2.83e-06 | 2 | 59 | 2 | 34459572 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 33763841 | ||
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 2.83e-06 | 2 | 59 | 2 | 37665666 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17881658 | ||
| Pubmed | Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. | 3.17e-06 | 59 | 59 | 4 | 17330941 | |
| Pubmed | 6.98e-06 | 22 | 59 | 3 | 16524884 | ||
| Pubmed | Cloning and analysis of a murine PIAS family member, PIASgamma, in developing skin and neurons. | 8.48e-06 | 3 | 59 | 2 | 10854042 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 32845893 | ||
| Pubmed | Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11. | 8.48e-06 | 3 | 59 | 2 | 26503449 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 28518218 | ||
| Pubmed | Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. | 8.48e-06 | 3 | 59 | 2 | 24704313 | |
| Pubmed | The sorting receptor Rer1 controls Purkinje cell function via voltage gated sodium channels. | 8.48e-06 | 3 | 59 | 2 | 28117367 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 17928448 | ||
| Pubmed | Structural variability of the ubiquitin specific protease DUSP-UBL double domains. | 8.48e-06 | 3 | 59 | 2 | 22001210 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 26182346 | ||
| Pubmed | De novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy. | 8.48e-06 | 3 | 59 | 2 | 31054517 | |
| Pubmed | Protein interaction data set highlighted with human Ras-MAPK/PI3K signaling pathways. | 1.36e-05 | 179 | 59 | 5 | 18624398 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 17537961 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 35031483 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 11477070 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 15507114 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 29578003 | ||
| Pubmed | Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. | 1.69e-05 | 4 | 59 | 2 | 15961505 | |
| Pubmed | FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase family. | 1.69e-05 | 4 | 59 | 2 | 16148010 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 21156207 | ||
| Pubmed | Genome-Wide Association Mapping for Female Infertility in Inbred Mice. | 1.69e-05 | 4 | 59 | 2 | 27449513 | |
| Pubmed | SUMOylation modulates the transcription repressor function of RIP140. | 1.69e-05 | 4 | 59 | 2 | 18211901 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 15123625 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 11877418 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 18594453 | ||
| Pubmed | Models for discovery of targeted therapy in genetic epileptic encephalopathies. | 1.69e-05 | 4 | 59 | 2 | 28742937 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 12855578 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 20161521 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 28355569 | ||
| Pubmed | SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription. | 1.69e-05 | 4 | 59 | 2 | 16421255 | |
| Pubmed | Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. | 1.69e-05 | 4 | 59 | 2 | 11439351 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 26403403 | ||
| Pubmed | SUMO-1 modification of centrosomal protein hNinein promotes hNinein nuclear localization. | 2.82e-05 | 5 | 59 | 2 | 16154161 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 12177000 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 23202365 | ||
| Pubmed | Regulation of cardiac specific nkx2.5 gene activity by small ubiquitin-like modifier. | 2.82e-05 | 5 | 59 | 2 | 18579533 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 8468048 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 21288202 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 12393877 | ||
| Pubmed | Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylation. | 2.82e-05 | 5 | 59 | 2 | 15229330 | |
| Pubmed | 3.75e-05 | 38 | 59 | 3 | 28680062 | ||
| Pubmed | Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. | 4.23e-05 | 6 | 59 | 2 | 16144832 | |
| Pubmed | The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA. | 4.23e-05 | 6 | 59 | 2 | 22406621 | |
| Pubmed | Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation. | 4.23e-05 | 6 | 59 | 2 | 15208321 | |
| Pubmed | Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. | 4.23e-05 | 6 | 59 | 2 | 11867732 | |
| Pubmed | SUMOylation of RORalpha potentiates transcriptional activation function. | 4.23e-05 | 6 | 59 | 2 | 19041634 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 18541031 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 18832723 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 20159969 | ||
| Pubmed | A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. | 4.23e-05 | 6 | 59 | 2 | 23704280 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 16556917 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 4.23e-05 | 6 | 59 | 2 | 23652591 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 21624478 | ||
| Pubmed | Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. | 4.72e-05 | 41 | 59 | 3 | 18157088 | |
| Pubmed | SUMOylation of Csk Negatively Modulates its Tumor Suppressor Function. | 5.91e-05 | 7 | 59 | 2 | 31125786 | |
| Pubmed | ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator. | 5.91e-05 | 7 | 59 | 2 | 18656483 | |
| Pubmed | Precise spatial restriction of BMP signaling is essential for articular cartilage differentiation. | 5.91e-05 | 7 | 59 | 2 | 25758226 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 5.91e-05 | 7 | 59 | 2 | 25818041 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 17283066 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 22162396 | ||
| Pubmed | Human cystathionine beta-synthase is a target for sumoylation. | 5.91e-05 | 7 | 59 | 2 | 17087506 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 14609633 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 20034104 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 15272007 | ||
| Pubmed | Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways. | 5.91e-05 | 7 | 59 | 2 | 10684250 | |
| Pubmed | 6.27e-05 | 591 | 59 | 7 | 15231748 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 20351170 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 21953591 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 14752048 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 20972456 | ||
| Pubmed | Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes. | 7.87e-05 | 8 | 59 | 2 | 12393906 | |
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 12223491 | ||
| Interaction | PGR interactions | 3.94e-06 | 84 | 57 | 5 | int:PGR | |
| Interaction | DNAJC10 interactions | 8.37e-06 | 260 | 57 | 7 | int:DNAJC10 | |
| Interaction | SIAH2 interactions | 1.12e-05 | 104 | 57 | 5 | int:SIAH2 | |
| Interaction | SIAH1 interactions | 3.89e-05 | 223 | 57 | 6 | int:SIAH1 | |
| Interaction | GOLM1 interactions | 5.58e-05 | 145 | 57 | 5 | int:GOLM1 | |
| Interaction | SEL1L interactions | 5.58e-05 | 145 | 57 | 5 | int:SEL1L | |
| Interaction | HOOK1 interactions | 5.85e-05 | 240 | 57 | 6 | int:HOOK1 | |
| Interaction | CHAD interactions | 7.82e-05 | 5 | 57 | 2 | int:CHAD | |
| Cytoband | 3q22.1 | 2.35e-05 | 42 | 60 | 3 | 3q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q22 | 7.53e-04 | 135 | 60 | 3 | chr3q22 | |
| Cytoband | 1p36.21 | 3.12e-03 | 63 | 60 | 2 | 1p36.21 | |
| Cytoband | 1q41 | 3.41e-03 | 66 | 60 | 2 | 1q41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q22 | 3.83e-03 | 70 | 60 | 2 | chr2q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 4.38e-03 | 75 | 60 | 2 | chr1q31 | |
| GeneFamily | Zinc fingers MIZ-type | 5.36e-07 | 7 | 46 | 3 | 85 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.25e-04 | 9 | 46 | 2 | 1203 | |
| GeneFamily | Ubiquitin specific peptidases | 3.89e-04 | 56 | 46 | 3 | 366 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.10e-04 | 57 | 46 | 3 | 1179 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 1.05e-03 | 19 | 46 | 2 | 131 | |
| GeneFamily | PRAME family | 1.69e-03 | 24 | 46 | 2 | 686 | |
| GeneFamily | Collagens | 6.10e-03 | 46 | 46 | 2 | 490 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.48e-07 | 178 | 60 | 6 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 2.31e-07 | 192 | 60 | 6 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-06 | 145 | 60 | 5 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.81e-06 | 164 | 60 | 5 | f0499e6c1b17c4df72b18b294e3b53ef723da2ac | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 165 | 60 | 5 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 165 | 60 | 5 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.98e-06 | 166 | 60 | 5 | b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-06 | 184 | 60 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-06 | 184 | 60 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-06 | 184 | 60 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COPD-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 5.33e-06 | 187 | 60 | 5 | be42ee71d3412bb1f52593d8814de85c354a0efa | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 5.62e-06 | 189 | 60 | 5 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 5.91e-06 | 191 | 60 | 5 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | COPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class | 6.22e-06 | 193 | 60 | 5 | 1c701b6ab5f0f0239634adac94fa1c92bf3c36f4 | |
| ToppCell | Control-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 6.22e-06 | 193 | 60 | 5 | 52c0f2c7af57436f23e0c0e0c87086c47695e2c4 | |
| ToppCell | Control-Endothelial-VE_Arterial|Control / Disease state, Lineage and Cell class | 6.54e-06 | 195 | 60 | 5 | 56c66a3655820961e1390b8f4bcc5618e8d0c5a8 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.22e-06 | 199 | 60 | 5 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 160 | 60 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 160 | 60 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.59e-05 | 161 | 60 | 4 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.59e-05 | 161 | 60 | 4 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.59e-05 | 161 | 60 | 4 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.59e-05 | 161 | 60 | 4 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-05 | 162 | 60 | 4 | 68c40d12689cc1b6c797e6e48173f0110f8144e4 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.75e-05 | 162 | 60 | 4 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-05 | 162 | 60 | 4 | 735fa3f77b31a4189e431d05c326403c18cbbffb | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 165 | 60 | 4 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_CCDC184|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.59e-05 | 167 | 60 | 4 | ef3ef83c213e818597600da15764c5b37763d7b6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.77e-05 | 168 | 60 | 4 | 2572a3dd4f3f619bd26a3cd6e60de43821d8bb64 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.90e-05 | 174 | 60 | 4 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.10e-05 | 175 | 60 | 4 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.10e-05 | 175 | 60 | 4 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.10e-05 | 175 | 60 | 4 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.10e-05 | 175 | 60 | 4 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 9.10e-05 | 175 | 60 | 4 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.10e-05 | 175 | 60 | 4 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.10e-05 | 175 | 60 | 4 | 085cceb1fc2c4ae2f27e85cea5702defecc2cf44 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.51e-05 | 177 | 60 | 4 | 6f6cf93893daac6ae228df36219ee3acf8de8f97 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-05 | 178 | 60 | 4 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.72e-05 | 178 | 60 | 4 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.72e-05 | 178 | 60 | 4 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.72e-05 | 178 | 60 | 4 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 181 | 60 | 4 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 181 | 60 | 4 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 181 | 60 | 4 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 183 | 60 | 4 | 1464b5c4425e8776c4aeb4d2b560481d4bf13931 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-04 | 183 | 60 | 4 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 185 | 60 | 4 | 492529121cb9e88bd3c0db6b54af3cd2979572bc | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-04 | 187 | 60 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 187 | 60 | 4 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 188 | 60 | 4 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 188 | 60 | 4 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 188 | 60 | 4 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 188 | 60 | 4 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 188 | 60 | 4 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 188 | 60 | 4 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 188 | 60 | 4 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 188 | 60 | 4 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 188 | 60 | 4 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 189 | 60 | 4 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 189 | 60 | 4 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.22e-04 | 189 | 60 | 4 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 189 | 60 | 4 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.22e-04 | 189 | 60 | 4 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 189 | 60 | 4 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-04 | 189 | 60 | 4 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 189 | 60 | 4 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-04 | 190 | 60 | 4 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.25e-04 | 190 | 60 | 4 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.25e-04 | 190 | 60 | 4 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.27e-04 | 191 | 60 | 4 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 60 | 4 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.27e-04 | 191 | 60 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-04 | 191 | 60 | 4 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 60 | 4 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 60 | 4 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 60 | 4 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 60 | 4 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.30e-04 | 192 | 60 | 4 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 192 | 60 | 4 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 192 | 60 | 4 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 192 | 60 | 4 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 192 | 60 | 4 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-04 | 192 | 60 | 4 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 192 | 60 | 4 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.30e-04 | 192 | 60 | 4 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 192 | 60 | 4 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-04 | 192 | 60 | 4 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-04 | 192 | 60 | 4 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 192 | 60 | 4 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-04 | 192 | 60 | 4 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.33e-04 | 193 | 60 | 4 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 193 | 60 | 4 | d08919db9601941569b9a143dad4d8e6f56a4389 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 193 | 60 | 4 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.33e-04 | 193 | 60 | 4 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 1.33e-04 | 193 | 60 | 4 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 193 | 60 | 4 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 193 | 60 | 4 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.33e-04 | 193 | 60 | 4 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 193 | 60 | 4 | 733f557bdc80293b40ccdf560f1675793df932d6 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.73e-06 | 13 | 55 | 3 | DOID:2531 (implicated_via_orthology) | |
| Disease | BMP-binding endothelial regulator protein measurement | 3.41e-06 | 2 | 55 | 2 | EFO_0020183 | |
| Disease | retinal detachment (is_implicated_in) | 3.41e-06 | 2 | 55 | 2 | DOID:5327 (is_implicated_in) | |
| Disease | dementia, Parkinson disease, disease progression measurement | 1.02e-05 | 3 | 55 | 2 | EFO_0008336, MONDO_0001627, MONDO_0005180 | |
| Disease | potassium voltage-gated channel subfamily F member 1 measurement | 3.40e-05 | 5 | 55 | 2 | EFO_0802890 | |
| Disease | mediator of RNA polymerase II transcription subunit 1 measurement | 5.09e-05 | 6 | 55 | 2 | EFO_0008228 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.52e-04 | 10 | 55 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.52e-04 | 10 | 55 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | transmembrane glycoprotein NMB measurement | 1.52e-04 | 10 | 55 | 2 | EFO_0008303 | |
| Disease | receptor-interacting serine/threonine-protein kinase 2 measurement | 1.86e-04 | 11 | 55 | 2 | EFO_0802997 | |
| Disease | craniosynostosis (is_implicated_in) | 2.22e-04 | 12 | 55 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.22e-04 | 12 | 55 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 2.63e-04 | 13 | 55 | 2 | EFO_0802114 | |
| Disease | intraocular pressure measurement | 3.62e-04 | 509 | 55 | 6 | EFO_0004695 | |
| Disease | cortical surface area change measurement, age at assessment | 5.72e-04 | 19 | 55 | 2 | EFO_0008007, EFO_0021503 | |
| Disease | optic disc size measurement | 5.85e-04 | 205 | 55 | 4 | EFO_0004832 | |
| Disease | gestational age, birth measurement | 7.00e-04 | 21 | 55 | 2 | EFO_0005112, EFO_0006921 | |
| Disease | complement factor H-like 1 protein measurement | 7.69e-04 | 22 | 55 | 2 | EFO_0600092 | |
| Disease | chronic kidney disease | 9.73e-04 | 235 | 55 | 4 | EFO_0003884 | |
| Disease | Malignant mesothelioma | 1.12e-03 | 109 | 55 | 3 | C0345967 | |
| Disease | aortic measurement | 1.24e-03 | 251 | 55 | 4 | EFO_0020865 | |
| Disease | complement factor H-related protein 2 measurement | 1.34e-03 | 29 | 55 | 2 | EFO_0600055 | |
| Disease | osteoarthritis, hip, body mass index | 1.44e-03 | 30 | 55 | 2 | EFO_0004340, EFO_1000786 | |
| Disease | HbA1c measurement | 1.57e-03 | 675 | 55 | 6 | EFO_0004541 | |
| Disease | word list delayed recall measurement, memory performance | 1.74e-03 | 33 | 55 | 2 | EFO_0004874, EFO_0006805 | |
| Disease | primary dental caries | 1.84e-03 | 34 | 55 | 2 | EFO_0600095 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DCKPWYCDKPPSKYI | 16 | A6NHR8 | |
| SSPECCKPDLKKLVW | 256 | Q16589 | |
| EKWSHPPSCIKTDCL | 976 | P08603 | |
| PGCKKWDTCAPEVIL | 241 | O95861 | |
| YEWALKKWSPCSKPC | 856 | O95450 | |
| KLKTVPEGDWFCPEC | 1181 | Q9NRL2 | |
| YNDKDVWKPEPCRIC | 41 | P02458 | |
| SWLCSKPFKVICIYI | 221 | O95156 | |
| SEITYLVPWCKLEKP | 126 | Q9UFN0 | |
| LKSQWIKETCYPDIP | 761 | Q99650 | |
| VCCKDLWYLETEKPP | 351 | P51610 | |
| DCQDLPVSYKCKCWP | 2941 | Q9NZR2 | |
| CTTEGWSPEPRCFKK | 76 | P05160 | |
| WSPEPRCFKKCTKPD | 81 | P05160 | |
| ECLTYGWSLTPKCTK | 196 | P05160 | |
| FWKKTVEDIYCDNPP | 116 | Q330K2 | |
| PKDYSWTDIRCPFEK | 311 | Q8IXQ5 | |
| KIAKVCGCPLYWKAP | 751 | Q06190 | |
| KKLDWSPSCFLPYCS | 281 | Q3SYG4 | |
| LSDTPPKACLKPCWD | 291 | O43316 | |
| FTTLKCECPAYLPWL | 136 | Q99489 | |
| CECPAYLPWLEKRIK | 141 | Q99489 | |
| TPAEQLLSKCPWKEY | 176 | O75400 | |
| PKSCVLGPIKWYKDC | 151 | Q9HB29 | |
| PDPCIEYELVLRKWC | 156 | O75794 | |
| DWVRLPSKCEVCKYV | 41 | Q9BT09 | |
| LREHSPCWKEKCPAY | 1741 | A8TX70 | |
| PCWKEKCPAYPTELV | 1746 | A8TX70 | |
| TYSWKKDIPIEVCPI | 396 | Q9NZK5 | |
| YNKAVWSPEPCTTCL | 111 | O94769 | |
| CVEIYIKSPSAPGKW | 131 | P16109 | |
| CCPWELSTLVKFAPY | 211 | Q5VWM4 | |
| LPAKSLCYNDCPWIK | 2461 | Q9NZJ4 | |
| LCYNDCPWIKVKDTT | 2466 | Q9NZJ4 | |
| AFRCCPWVTPTKEDK | 321 | P21452 | |
| TPKEKECEELKSCPW | 266 | Q5THK1 | |
| PTWICPVCDKKAAYE | 381 | O75928 | |
| GWIPIQYPIISECKC | 216 | Q13253 | |
| FLPEECPCTWKGKEY | 941 | Q6ZRI0 | |
| DKEPCCLPQWSVPKD | 861 | Q8TBY8 | |
| LCVTPYPEPSECSWK | 1086 | P26640 | |
| PDKYPSRKECTWEIS | 791 | O43897 | |
| IPCEEPACYDWKAVR | 566 | Q9UPZ6 | |
| LPCKKDCIVTPYSDW | 766 | Q9UPZ6 | |
| CGYVLKPPVLWDKNC | 1836 | Q9P212 | |
| EDCYLKTLSLCPPWL | 1186 | Q8TF17 | |
| DPKKDVLIEFYAPWC | 541 | P13667 | |
| PTTKEKCPRCWKYTA | 981 | Q9NSE4 | |
| TWVCPVCDKKAPYEH | 371 | O75925 | |
| ELEESRQKCPPCWYK | 726 | P35498 | |
| HIPPARWKLTCYICK | 376 | P55201 | |
| KPTWTCPVCDKKAPY | 361 | Q9Y6X2 | |
| KLWLSYFDDKCTLPP | 666 | P48995 | |
| CCPWELSTLVKFAPY | 211 | Q5VXH5 | |
| PKQKPTWRCEVCDYE | 761 | Q86UP3 | |
| EVLAPEEAWYCPQCK | 1071 | O94966 | |
| PYECPVCWKAFSQKS | 541 | P17025 | |
| PEAPTDECKPVKWCA | 351 | P02787 | |
| KEVYKDPPLCAWEAN | 26 | Q8NCR6 | |
| PKKIWDYTPGDCSIL | 581 | Q9BX66 | |
| KSWITPCPEEKAQYV | 776 | P80108 | |
| TTKEKLGAEDPWYCP | 796 | Q9Y4E8 | |
| ELEESQRKCPPCWYK | 711 | Q9UQD0 | |
| VETLEKENPWYCPSC | 791 | P51784 | |
| PLKDCTYGTEIISKW | 441 | Q9UBB9 | |
| KCVWKFLEKPESSCP | 166 | Q9H3M0 | |
| PVFYWKKDNETIPCT | 1201 | Q86TC9 |